Market Tracker

05/25 12:54pm ET

Repligen Corp (NASDAQ:RGEN)

24.39
Delayed Data
As of 12:30pm ET
 +0.27 / +1.12%
Today’s Change
20.07
Today|||52-Week Range
42.48
-13.79%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close24.12
Today’s open24.21
Day’s range24.12 - 24.80
Volume145,772
Average volume (3 months)331,877
Market cap$811.4M
Dividend yield--
Data as of 12:30pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio101.9
Price/Sales11.37
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.76+3.24%
SRPTSarepta Therapeutics...+3.65+19.79%
LCILannett Company Inc+0.24+1.04%
EGRXEagle Pharmaceutical...-0.47-0.95%
Data as of 12:54pm ET, 05/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts